Numerous environmental contaminants have been shown to have potential carcinogenic (cancer-causing) consequences. [3] Events such as 9/11 are just some of the scenarios that have alerted government agencies, the medical community, and individuals to study the types of common cancers from each scenario. These exposures also bring new (and heightened) concerns for gene mutations that may be inherited or passed down to the next generations of those directly impacted.
"Learning about how cancer and other illnesses work... I would hate to contract this on the job and give this to my kids", states FDNY Ret. FF Sal Banchitta- 9/11 responder. "Firefighters get a lot of training and gear to protect us from exposure- but let's face it... part of the risk of the job is that there IS no 100% guarantee- ever! Looking back on all this, from the local house fires of burning plastics and PVC's to the many chemicals and airborne poisons in ground zero-- exposure came from anywhere. You can only hope that you're not someone who's predisposed, but you never know."
Genes are specific regions of DNA that contain the code for all of the proteins that run our biology. Gene expression is the ultimate result of this complex process, and gene expression research has greatly accelerated the study of human biology and improved the practice of medicine. Up until the completion of the Human Genome Project in 2003, much of the focus had been on studying rare mutations linked to specific inherited diseases and cancers. We now know that these alterations of the DNA code are not the only ways people can be predisposed.
The most common types of changes in DNA are called SNPs (single nucleotide polymorphisms), and we each have millions of these. These SNPs can alter our biochemistry and biology, but they typically have a much smaller effect individually than mutations. However, the additive effect of multiple SNPs can create significant predispositions to (or protection from) most diseases, including cancer.
The latest gene expression research has added a third layer called epigenetics. Epigenetic changes don’t affect the DNA or genetic code itself. Rather, they respond to environmental cues to control when genes are turned on or off. Therefore, epigenetic changes can be easily modified throughout a person’s lifetime.
Genetic testing supports proactive prevention initiatives and active surveillance for these specific cancers that continue to prevail. Gene SNP testing can further support personalized prevention and screening strategies. While epigenetics is emerging as another tool in efforts to identify predispositions and personalize strategies, it is still more informative than prognostic at this time.
Though currently testing negative for cancer, Samantha continues to undergo early detection through gene testing, ultrasound screening and maintains a significantly strict lifestyle of prevention (eating healthy/organic foods, no sugar, exercise, organic foods etc). Early in life, she learned the value of staying proactive and getting a second opinion- never resting on reassuring words from physicians. "Early on, my gyno didn't express any real sense of urgency about me getting an ultrasound test but gave me the referral just to make me happy...", stated Ms. Hunt. "Even today (and sometimes even in the past with other breast exams), I often feel like they do it so quickly and carelessly, and I feel stressed out after... I'm not convinced that I'm getting a proper examination!"
Samantha has received a total of 4 biopsies due to the "abnormally dense" breast tissue- a concern that scientists are now linking to breast cancer. [13] At an early age, Samantha took on a significant leadership role in her health to approve the biopsies despite the risk and concerns from her parents. "After my first sono, they found me to be 'very lumpy' and called on me to get a biopsy. None of us were excited about this but if I was going to get any peace of mind, I made a decision to go for it and I'm glad I did. Honestly think I'd be more anxious knowing there's something that a doctor recommended that I should get a biopsy on!"
References:
1) https://www.nyc.gov/site/911health/enrollees/rescue-recovery-workers.page
2) The Toll of Heroism: Increased Cancer Incidence Among 9/11 Responders
September 9, 2022 by Calley Jones, PhD https://www.aacr.org/blog/2022/09/09/the-toll-of-heroism-increased-cancer-incidence-among-9-11-responders/
3) Tuminello S, Nguyen E, Durmus N, et al. World Trade Center Exposure, DNA Methylation Changes, and Cancer: A Review of Current Evidence. Epigenomes. 2023; 7(4):31. https://doi.org/10.3390/epigenomes7040031
4) https://www.cancer.gov/about-cancer/causes-prevention/genetics
5) https://www.cdc.gov/wtc/ataglance.html#top15Cancers
6) Yu, H., Tuminello, S., Alpert, et al/ (2022) Global DNA methylation of WTC prostate cancer tissues show signature differences compared to non-exposed cases. Carcinogenesis, 43(6), 528-537. https://doi.org/10.1093/carcin/bgac025
7) Tuminello S, Zhang Y, Yang L, et al. Global DNA Methylation Profiles in Peripheral Blood of WTC-Exposed Community Members with Breast Cancer. Int J Environ Res Public Health. 2022 Apr 22;19(9):5104. doi: 10.3390/ijerph19095104.
8) Jasra, S., Giricz, O., Pradhan, K., et al (2022). High burden of clonal hematopoiesis in first responders exposed to the World Trade Center disaster. Nature Medicine, 28(3), 468-471. https://doi.org/10.1038/s41591-022-01708-3
9) https://www.cancer.gov/about-cancer/causes-prevention/genetics/genetic-testing-fact-sheet
10) Daly MB, Pal T, Maxwell KN, et al. NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024. Journal of the National Comprehensive Cancer Network 2023; 21(10):1000–1010. doi: 10.6004/jnccn.2023.0051.
11) Garber J, Offit K. Hereditary cancer predisposition syndromes. Journal of Clinical Oncology 2005; 23(2):276–292.
12) https://www.cdc.gov/cancer/breast/basic_info/dense-breasts.htm
13) Lester, S. P., Kaur, A. S., & Vegunta, S. (2022). Association Between Lifestyle Changes, Mammographic Breast Density, and Breast Cancer. The Oncologist, 27(7), 548-554. https://doi.org/10.1093/oncolo/oyac084
No comments:
Post a Comment